215 related articles for article (PubMed ID: 2887329)
1. Molecular mechanism of multidrug resistance in tumor cells.
Roninson IB
Clin Physiol Biochem; 1987; 5(3-4):140-51. PubMed ID: 2887329
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance.
Gerlach JH; Kartner N; Bell DR; Ling V
Cancer Surv; 1986; 5(1):25-46. PubMed ID: 2885085
[TBL] [Abstract][Full Text] [Related]
3. Genes amplified and overexpressed in human multidrug-resistant cell lines.
Van der Bliek AM; Baas F; Van der Velde-Koerts T; Biedler JL; Meyers MB; Ozols RF; Hamilton TC; Joenje H; Borst P
Cancer Res; 1988 Nov; 48(21):5927-32. PubMed ID: 2901906
[TBL] [Abstract][Full Text] [Related]
4. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
5. Molecular targets in oncology: implications of the multidrug resistance gene.
Lum BL; Gosland MP; Kaubisch S; Sikic BI
Pharmacotherapy; 1993; 13(2):88-109. PubMed ID: 8097038
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance: a transport system of antitumor agents and xenobiotics.
Tsuruo T
Princess Takamatsu Symp; 1990; 21():241-51. PubMed ID: 1983721
[TBL] [Abstract][Full Text] [Related]
7. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance: molecular and clinical aspects.
Dicato M; Duhem C; Pauly M; Ries F
Cytokines Cell Mol Ther; 1997 Jun; 3(2):91-9. PubMed ID: 9287248
[TBL] [Abstract][Full Text] [Related]
9. Transfer of the MDR1 (multidrug resistance) gene: protection of hematopoietic cells from cytotoxic chemotherapy, and selection of transduced cells in vivo.
Licht T; Gottesman MM; Pastan I
Cytokines Mol Ther; 1995 Mar; 1(1):11-20. PubMed ID: 9384659
[TBL] [Abstract][Full Text] [Related]
10. [Multidrug resistance (MDR)].
Wada M; Hasegawa S; Kohno K; Kuwano M
Gan To Kagaku Ryoho; 1994 Jun; 21(7):936-44. PubMed ID: 8002631
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
Kaye SB
Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance: prospects for clinical management.
Mansouri A; Henle KJ; Nagle WA
SAAS Bull Biochem Biotechnol; 1992 Jan; 5():48-52. PubMed ID: 1375033
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM
Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
15. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
16. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
[TBL] [Abstract][Full Text] [Related]
17. Intracellular P-glycoprotein in multidrug resistant tumor cells.
Arancia G; Molinari A; Calcabrini A; Meschini S; Cianfriglia M
Ital J Anat Embryol; 2001; 106(2 Suppl 1):59-68. PubMed ID: 11729998
[TBL] [Abstract][Full Text] [Related]
18. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
19. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
[TBL] [Abstract][Full Text] [Related]
20. [Regulation of the multidrug resistance (MDR)1 gene expression].
Kohno K; Kuwano M
Gan To Kagaku Ryoho; 1990 Oct; 17(10):1975-81. PubMed ID: 2221922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
